HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 6.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,307,956 shares of the company's stock after selling 97,353 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.52% of HCA Healthcare worth $392,585,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter worth about $840,286,000. Royal London Asset Management Ltd. increased its stake in HCA Healthcare by 62.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock worth $450,461,000 after buying an additional 574,239 shares in the last quarter. Barclays PLC raised its position in shares of HCA Healthcare by 85.7% in the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after buying an additional 489,916 shares during the last quarter. Principal Financial Group Inc. raised its holdings in HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock valued at $262,264,000 after acquiring an additional 476,756 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $74,121,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.6 %

HCA traded up $2.18 on Wednesday, reaching $342.76. 338,262 shares of the company's stock were exchanged, compared to its average volume of 1,392,003. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company's 50 day moving average is $330.44 and its 200-day moving average is $331.39. The company has a market cap of $84.39 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same period last year, the firm earned $5.36 earnings per share. The company's revenue was up 5.7% on a year-over-year basis. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Royal Bank of Canada reduced their price target on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday. Finally, StockNews.com raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $381.13.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.